News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,306 Results
Type
Article (13712)
Company Profile (101)
Press Release (250493)
Section
Business (88015)
Career Advice (465)
Deals (15356)
Drug Delivery (66)
Drug Development (36580)
Employer Resources (49)
FDA (6283)
Job Trends (6195)
News (150175)
Policy (14022)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Pharm Country Standard (1)
Academia (438)
Adcomms (6)
Allergies (28)
Alliances (23202)
ALS (32)
Alzheimer's disease (377)
Antibody-drug conjugate (ADC) (33)
Approvals (6307)
Artificial intelligence (93)
Autoimmune disease (4)
Automation (3)
Bankruptcy (146)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (49)
Biotechnology (40)
Bladder cancer (17)
Brain cancer (13)
Breast cancer (70)
Cancer (521)
Cardiovascular disease (54)
Career advice (406)
Career pathing (10)
CAR-T (17)
Cell therapy (74)
Cervical cancer (4)
Clinical research (30766)
Collaboration (286)
Compensation (116)
Complete response letters (16)
COVID-19 (754)
CRISPR (18)
C-suite (99)
Cystic fibrosis (35)
Data (524)
Denatured (15)
Depression (9)
Diabetes (70)
Diagnostics (1315)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (50)
Drug pricing (61)
Drug shortages (11)
Duchenne muscular dystrophy (26)
Earnings (31877)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37241)
Executive appointments (323)
FDA (6618)
Featured Employer (21)
Friedreich's ataxia (2)
Funding (179)
Gene editing (34)
Generative AI (8)
Gene therapy (90)
GLP-1 (324)
Government (1281)
Grass and pollen (2)
Guidances (14)
Healthcare (3556)
Huntington's disease (4)
IgA nephropathy (8)
Immunology and inflammation (24)
Indications (10)
Infectious disease (783)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (35)
Interviews (59)
IPO (5885)
IRA (28)
Job creations (2051)
Job search strategy (372)
Kidney cancer (6)
Labor market (7)
Layoffs (176)
Leadership (3)
Legal (3427)
Liver cancer (18)
Lung cancer (71)
Lymphoma (45)
Machine learning (1)
Management (16)
Manufacturing (127)
MASH (28)
Medical device (1272)
Medtech (1274)
Mergers & acquisitions (9622)
Metabolic disorders (222)
Multiple sclerosis (16)
NASH (14)
Neurodegenerative disease (19)
Neuropsychiatric disorders (5)
Neuroscience (529)
NextGen: Class of 2025 (1585)
Non-profit (593)
Northern California (621)
Now hiring (7)
Obesity (126)
Opinion (116)
Ovarian cancer (18)
Pain (44)
Pancreatic cancer (13)
Parkinson's disease (39)
Partnered (5)
Patents (91)
Patient recruitment (26)
Peanut (9)
People (28777)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8008)
Phase II (13015)
Phase III (11678)
Pipeline (307)
Podcasts (44)
Policy (54)
Postmarket research (1401)
Preclinical (3191)
Press Release (25)
Prostate cancer (40)
Psychedelics (8)
Radiopharmaceuticals (118)
Rare diseases (147)
Real estate (2632)
Recruiting (17)
Regulatory (10022)
Reports (13)
Research institute (563)
Resumes & cover letters (55)
RSV (6)
Schizophrenia (31)
Series A (32)
Series B (11)
Service/supplier (3)
Sickle cell disease (30)
Southern California (622)
Special edition (5)
Sponsored (6)
Startups (1626)
State (2)
Stomach cancer (3)
Supply chain (27)
The Weekly (28)
United States (6226)
Vaccines (136)
Venture capitalists (13)
Webinars (10)
Weight loss (89)
Women's health (8)
Worklife (3)
Date
Today (59)
Last 7 days (285)
Last 30 days (1099)
Last 365 days (12370)
2025 (2117)
2024 (12511)
2023 (14262)
2022 (19562)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11713)
2017 (13891)
2016 (13129)
2015 (15473)
2014 (12419)
2013 (10594)
2012 (11397)
2011 (11924)
2010 (10889)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (46)
Arkansas (3)
Asia (20018)
Australia (2595)
California (1491)
Canada (813)
China (195)
Colorado (61)
Connecticut (62)
Delaware (49)
Europe (39220)
Florida (267)
Georgia (34)
Idaho (9)
Illinois (167)
India (11)
Indiana (120)
Iowa (1)
Japan (76)
Kansas (54)
Kentucky (12)
Maine (2)
Maryland (227)
Massachusetts (1277)
Michigan (27)
Minnesota (82)
Missouri (21)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (640)
New Mexico (7)
New York (423)
North Carolina (353)
North Dakota (2)
Northern California (621)
Ohio (43)
Oklahoma (4)
Oregon (16)
Pennsylvania (374)
Puerto Rico (5)
Rhode Island (5)
South America (500)
South Carolina (2)
Southern California (622)
Tennessee (29)
Texas (200)
Utah (32)
Virginia (65)
Washington D.C. (29)
Washington State (101)
Wisconsin (12)
264,306 Results for "newbridge pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
BeiGene and NewBridge Pharmaceuticals Announce Approval in Saudi Arabia of BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma
BeiGene and NewBridge Pharmaceuticals announced that BRUKINSA® has received approval from the Saudi Food and Drug Authority for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy.
November 14, 2021
·
14 min read
Press Releases
Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
March 4, 2025
·
1 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales
February 25, 2025
·
9 min read
Press Releases
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
March 3, 2025
·
21 min read
Press Releases
Eupraxia Pharmaceuticals Announces CFO Succession
February 18, 2025
·
8 min read
Press Releases
Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
February 24, 2025
·
1 min read
Press Releases
JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors
February 20, 2025
·
13 min read
Press Releases
CNS Pharmaceuticals Announces Reverse Stock Split
February 19, 2025
·
4 min read
Layoffs
X4 Pharmaceuticals Stumbles Again, Laying Off 30% of Workforce
The headcount reduction will save money that the company will use in developing mavorixafor, its CXCR4 antagonist that last year received FDA approval to treat WHIM syndrome, in the larger patient population with chronic neutropenia.
February 6, 2025
·
1 min read
·
Dan Samorodnitsky
1 of 26,431
Next
